In recent months, Madrid has drawn a series of landmark investments that confirm the region’s rising status as a powerhouse in the life sciences sector. Pharmaceutical giant Eli Lilly has announced a $175 million investment to transform its Alcobendas plant into a Global Packaging Centre of Excellence. The project, running through 2030, will create 75 highly skilled jobs and further consolidate Madrid’s role as a key node in global supply chains.
Equally significant, Argentine pharmaceutical group Insud Pharma announced in March a €100 million+ investment in its Química Sintética facilities in Alcalá de Henares — a project granted special status by the Community of Madrid’s Investment Accelerator. This regional mechanism, created in 2023 to halve administrative timelines for major projects, currently oversees 15 priority initiatives representing €5.7 billion in investment and nearly 10,000 jobs to be created. Insud Pharma’s investment alone is expected to generate around a hundred direct, highly skilled permanent positions, and forms part of the region’s own Biopharmaceutical Sector Strategy 2025–2028.
In Arganda del Rey, construction is underway for what will become Europe’s largest soft-gel pharmaceutical capsule manufacturing facility: a five-building complex covering 7,400 m², expected to be fully operational by the end of the year.
Why Madrid? Key Advantages for International Investors
For German companies looking to expand within the EU, the Madrid region offers a compelling combination of factors:
- Strategic location : a single base providing access to European, Latin American and North African markets
- Established industrial infrastructure : more than 35 pharmaceutical and medtech companies already operating in the region, forming a mature ecosystem of suppliers and talent
- Competitive operating costs compared to major European hubs such as Munich, Frankfurt or Basel
- A skilled, multilingual workforce, underpinned by a €14.8 billion public university funding agreement running through 2031
Add to this what international investors consistently describe as “regulatory predictability and reduced bureaucracy“, a decisive factor in site selection.
Digital Health: The Next Frontier
Beyond manufacturing, Madrid is positioning itself as a leader in digital health and predictive medicine. The region’s new Digital Health Strategic Plan sets out an ambitious roadmap to build a healthcare system of the future, one where data follows the patient. This vision was showcased at the recent Mobile World Congress 2026, to the keen attention of global medtech and health technology players.
Madrid: A Region That Invests Alongside You
Madrid does not simply attract investment, it actively co-builds projects. The region provides end-to-end support for investors, entrepreneurs and project developers: site identification, administrative facilitation, talent sourcing and connection to local networks and stakeholders.